Reinventing FP&A: Key Lessons Learned from the Pandemic
The first post pandemic face-to-face FP&A Board in Boston was held on June 21, and it brought around 22 senior practitioners from such companies as Moderna Therapeutics, Takeda Pharmaceuticals USA, MBTA, Novartis, Foundation Medicine, PTC, MassMutual, Philips, etc.
We were discussing the key lessons learned from the pandemic.
Agenda
- FP&A for the Next Normal
- Top lessons learned from the Pandemic
- Moderna case study: Scaling FP&A during Pandemic; presented by Svetlana Sigalova, Vice President, FP&A at Moderna
- Group work
- Conclusions and recommendations
Our Sponsors
We are very grateful to our global sponsors and partners SAP and IWG for their great support.
